TrialIn vivo (Athens, Greece)

Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102.

Toshifumi Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.